CNS disorders are often treated ineffectively by trial-and-error, causing prolonged patient distress and high healthcare costs. Neumarker aims to transform the treatment of CNS disorders through its cutting-edge brain biomarker discovery platform, powered by AI. By identifying predictive brain biomarkers, we can personalize treatment for each patient and accelerate drug development by efficient clinical trials. Neumarker is committed to advancing precision neuromedicine through collaborations with drug developers, clinicians and academic researchers.
Company Details
- Employees
- 10
- Founded
- 2022
- Address
- Palo Alto, California 94303, Us
- Industry
- Mental Health Care
- NAICS
-
Offices of Mental Health Practitioners (except Physicians)
- Website
- http://neumarker.ai/
- HQ
- Palo Alto, California
Neumarker Inc. Questions
Neumarker Inc.'s website is http://neumarker.ai/
Neumarker Inc.'s LinkedIn profile is https://www.linkedin.com/company/neumarker-inc
Neumarker Inc. has
10 employees.
View email and phone details for 10
employees at Neumarker Inc..
Neumarker Inc.'s industry is
Mental Health Care
Neumarker Inc.'s top competitors are
Vagus Labs,
Sama Therapeutics,
Holobiome,
Thynk Inc,
Sensorium Therapeutics,
Reulay Inc,
Ceretype Neuromedicine, Inc.,
Ferry Venture Capital,
Hearts & Minds Activity Center,
Torpedo Therapeutics.
Neumarker Inc.'s categories are Mental Health Care
Neumarker Inc.'s founding year is 2022
